Patents by Inventor David S. HUANG

David S. HUANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240290788
    Abstract: A metal gate fabrication method for nanoribbon-based transistors and associated transistor arrangements, IC structures, and devices are disclosed. An example IC structure fabricated using metal gate fabrication method described herein may include a first stack of N-type nanoribbons, a second stack of P-type nanoribbons, a first gate region enclosing portions of the nanoribbons of the first stack and including an NWF material between adjacent nanoribbons of the first stack, and a second gate region enclosing portions of the nanoribbons of the second stack and including a PWF material between adjacent nanoribbons of the second stack, where the second gate region includes the PWF material at sidewalls of the nanoribbons of the second stack and further includes the NWF material so that the PWF material is between the sidewalls of the nanoribbons of the second stack and the NWF material.
    Type: Application
    Filed: February 28, 2023
    Publication date: August 29, 2024
    Applicant: Intel Corporation
    Inventors: Guowei Xu, Tao Chu, Chiao-Ti Huang, Robin Chao, David Towner, Orb Acton, Omair Saadat, Feng Zhang, Dax M. Crum, Yang Zhang, Biswajeet Guha, Oleg Golonzka, Anand S. Murthy
  • Publication number: 20240101550
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: September 27, 2023
    Publication date: March 28, 2024
    Inventors: Rishi G. VASWANI, David S. HUANG
  • Publication number: 20230416248
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: November 10, 2021
    Publication date: December 28, 2023
    Inventors: Kevin J. WILSON, Solymar NEGRETTI, Shawn E.R. SCHILLER, Rishi G. VASWANI, David S. HUANG, Johannes H. VOIGT
  • Publication number: 20230365560
    Abstract: The present disclosure features compounds of Formula I, or pharmaceutically acceptable salts thereof, and formulations containing the same. Methods of treating BAF complex-related disorders, such as cancer, are also disclosed.
    Type: Application
    Filed: May 11, 2023
    Publication date: November 16, 2023
    Inventors: Shawn E.R. SCHILLER, Solymar NEGRETTI, David S. HUANG, Kevin J. WILSON, Melek Nihan UCISIK, Richard CALDWELL
  • Publication number: 20230129003
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: October 11, 2022
    Publication date: April 27, 2023
    Inventors: Rishi G. VASWANI, David S. HUANG
  • Publication number: 20230121497
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: April 20, 2023
    Inventors: Rishi G. VASWANI, David S. HUANG, Kevin J. WILSON, Shawn E.R. SCHILLER, Neville John ANTHONY
  • Publication number: 20230079819
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2020
    Publication date: March 16, 2023
    Inventors: Rishi G. VASWANI, Neville John ANTHONY, David Simon MILLAN, Shawn E.R. SCHILLER, Kevin J. WILSON, David S. HUANG
  • Patent number: 11485732
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Grant
    Filed: January 29, 2021
    Date of Patent: November 1, 2022
    Assignee: Foghorn Therapeutics Inc.
    Inventors: Rishi G. Vaswani, David S. Huang
  • Patent number: 11312722
    Abstract: Herein is described the design and synthesis of resorcylate aminopyrazole compounds. These compounds show broad, potent and fungal-selective Hsp90 inhibitory activity. These compounds also find use in treating Hsp90 related diseases.
    Type: Grant
    Filed: May 6, 2020
    Date of Patent: April 26, 2022
    Assignees: TRUSTEES OF BOSTON UNIVERSITY, The Governing Council of the University of Toronto
    Inventors: Lauren Elaine Brown, David S Huang, Leah E. Cowen, Luke Whitesell, Paul Marcyk
  • Publication number: 20210230154
    Abstract: The present disclosure features compounds useful for the treatment of BAF complex-related disorders.
    Type: Application
    Filed: January 29, 2021
    Publication date: July 29, 2021
    Inventors: Rishi G. VASWANI, David S. HUANG